- TWD2.90bn
 - TWD2.07bn
 - TWD153.56m
 
- 37
 - 12
 - 58
 - 24
 
Annual balance sheet for Phytohealth, fiscal year end - December 31st, TWD millions except per share, conversion factor applied.
C2020 December 31st  | 2021 December 31st  | 2022 December 31st  | 2023 December 31st  | 2024 December 31st  | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — | 
| Source: | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | Annual Audited Accounts | 
| Standards: | IFRS | IFRS | IFRS | IFRS | IFRS | 
| Status: | Final | Final | Final | Final | Final | 
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 759 | 1,415 | 1,361 | 1,266 | 1,080 | 
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 14.1 | 20.4 | 25.6 | 36.1 | 40.6 | 
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 962 | 1,618 | 1,568 | 1,499 | 1,306 | 
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 263 | 307 | 275 | 246 | 214 | 
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,810 | 2,470 | 2,365 | 2,351 | 2,440 | 
| Accounts Payable | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 77.4 | 56.2 | 62.1 | 57.4 | 54.4 | 
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 526 | 489 | 457 | 423 | 538 | 
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Unrealized Gain / Loss | |||||
| Total Equity | 1,284 | 1,981 | 1,908 | 1,927 | 1,901 | 
| Total Liabilities & Shareholders' Equity | 1,810 | 2,470 | 2,365 | 2,351 | 2,440 | 
| Total Common Shares Outstanding |